Produktdetaljer
Biografisk notat
Athénaïs Boucly is an associate professor of respiratory medicine at Université Paris-Saclay (Le Kremlin-Bicêtre, France) and a consultant at the French Referral Centre for Pulmonary Hypertension at Hôpital Bicêtre (Le Kremlin-Bicêtre). Gabor Kovacs is an associate professor of respiratory medicine and works at the Division of Respiratory Medicine of the Medical University of Graz (Graz, Austria), where he leads the Pulmonary Hypertension Research Unit. Robin Condliffe is a consultant respiratory physician at the Sheffield Pulmonary Vascular Disease Unit (Sheffield, UK), and an honorary professor in pulmonary hypertension at the University of Sheffield (Sheffield).
This issue of the ERS Monograph captures the diversity of pulmonary hypertension in a rapidly changing field. Guest Editors Athénaïs Boucly, Gabor Kovacs and Robin Condliffe have invited world-leading experts to write chapters covering epidemiology and assessment, approaches to diagnosis and management, the application of artificial intelligence and remote monitoring, comorbidities, and multifactorial disease. This issue will educate, challenge and stimulate – it is a useful resource for all healthcare professionals and researchers with an interest in pulmonary hypertension.
This issue of the ERS Monograph captures the diversity of pulmonary hypertension in a rapidly changing field – it is a useful resource for all healthcare professionals and researchers with an interest in pulmonary hypertension.
- The epidemiology of pulmonary hypertension
- Artificial intelligence in the diagnosis of pulmonary hypertension
- The role of cardiopulmonary exercise testing in the diagnosis and prognostic assessment of pulmonary hypertension
- Right heart catheterisation in the assessment of suspected pulmonary hypertension
- The emerging role of omics in pulmonary hypertension
- Remote monitoring in pulmonary arterial hypertension
- Heritable pulmonary (arterial) hypertension
- Pulmonary arterial hypertension associated with connective tissue diseases
- Pulmonary arterial hypertension associated with adult congenital heart disease
- Portopulmonary hypertension
- Nonpharmacological management of pulmonary arterial hypertension
- New drugs in development for pulmonary arterial hypertension
- Pulmonary hypertension in pregnancy
- Tricuspid regurgitation in pulmonary arterial hypertension
- Lung transplantation for pulmonary hypertension
- Pulmonary hypertension in left heart disease
- Pulmonary hypertension associated with interstitial lung disease
- Pulmonary hypertension in COPD and emphysema
- Association of sleep disordered breathing and hypoventilation syndromes with pulmonary hypertension, and sleep disordered breathing in pulmonary vascular disease
- Ventilation/perfusion mismatch in pulmonary hypertension associated with chronic lung disease and its therapeutic implications
- Group 1, 2 or 3? Classifying patients with pulmonary hypertension and comorbidities
- Pulmonary hypertension at high altitude
- Development of chronic thromboembolic pulmonary hypertension after pulmonary embolism
- Controversies in the optimal management of chronic thromboembolic pulmonary hypertension
- Pulmonary hypertension associated with sickle cell disease
- Pulmonary hypertension and pulmonary vascular disease in hereditary haemorrhagic telangiectasia
Produktdetaljer
Biografisk notat
Athénaïs Boucly is an associate professor of respiratory medicine at Université Paris-Saclay (Le Kremlin-Bicêtre, France) and a consultant at the French Referral Centre for Pulmonary Hypertension at Hôpital Bicêtre (Le Kremlin-Bicêtre). Gabor Kovacs is an associate professor of respiratory medicine and works at the Division of Respiratory Medicine of the Medical University of Graz (Graz, Austria), where he leads the Pulmonary Hypertension Research Unit. Robin Condliffe is a consultant respiratory physician at the Sheffield Pulmonary Vascular Disease Unit (Sheffield, UK), and an honorary professor in pulmonary hypertension at the University of Sheffield (Sheffield).